timkiely,
I don't see what your problem is. The wording is what it is. It is not confusing imho.
It is also plain to see that there is a level of improvement above what would be expected from the standard care.
It is obvious from your posts that you are a smart person, so I don't quite understand why you find the information provided by the company as confusing.
It has been stated beforehand that ftt's offers a 300% improvement in wound healing time, and the data provided suggests that that is the case again, assuming that the placebo is acting as placebo's normally do (giving a small degree of improvement).
cheers
- Forums
- ASX - By Stock
- DLM
- Ann: Clinical Trial Update
Ann: Clinical Trial Update, page-27
Featured News
Add DLM (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable